These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24165277)

  • 1. Detection of lamivudine-resistant variants and mutations related to reduced antigenicity of HBsAg in individuals from the cities of Santos and São Paulo, Brazil.
    Mantovani N; Cicero M; Santana LC; Silveira C; do Carmo EP; Abrão PR; Diaz RS; Caseiro MM; Komninakis SV
    Virol J; 2013 Oct; 10():320. PubMed ID: 24165277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the
    Arikan A; Sayan M; Sanlidag T; Suer K; Akcali S; Guvenir M
    Pol J Microbiol; 2019 Sep; 68(3):317-322. PubMed ID: 31880877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene.
    Torresi J; Earnest-Silveira L; Civitico G; Walters TE; Lewin SR; Fyfe J; Locarnini SA; Manns M; Trautwein C; Bock TC
    Virology; 2002 Jul; 299(1):88-99. PubMed ID: 12167344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV therapy with unknown HBV status is responsible for higher rate of HBV genome variability in Ethiopia.
    Belyhun Y; Maier M; Liebert UG
    Antivir Ther; 2017; 22(2):97-111. PubMed ID: 27354181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HBV pol/S gene mutations in chronic hepatitis B patients receiving nucleoside/nucleotide analogues treatment].
    Kırdar S; Yaşa MH; Sayan M; Aydın N
    Mikrobiyol Bul; 2019 Apr; 53(2):144-155. PubMed ID: 31130119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New amino acid changes in drug resistance sites and HBsAg in hepatitis B virus genotype H.
    Fernández-Galindo DA; Sánchez-Ávila F; Bobadilla-Morales L; Gómez-Quiróz P; Bueno-Topete M; Armendáriz-Borunda J; Sánchez-Orozco LV
    J Med Virol; 2015 Jun; 87(6):985-92. PubMed ID: 25732900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HBV vaccine escape mutations in a chronic hepatitis B patient treated with nucleos(t)ide analogues].
    Sayan M; Buğdacı MS
    Mikrobiyol Bul; 2013 Jul; 47(3):544-9. PubMed ID: 23971933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBV carrying drug-resistance mutations in chronically infected treatment-naive patients.
    Gomes-Gouvêa MS; Ferreira AC; Teixeira R; Andrade JR; Ferreira AS; Barros LM; Rezende RE; Nastri AC; Leite AG; Piccoli LZ; Galvan J; Conde SR; Soares MC; Kliemann DA; Bertolini DA; Kunyoshi AS; Lyra AC; Oikawa MK; de Araújo LV; Carrilho FJ; Mendes-Corrêa MC; Pinho JR
    Antivir Ther; 2015; 20(4):387-95. PubMed ID: 25624410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B.
    Coppola N; Tonziello G; Colombatto P; Pisaturo M; Messina V; Moriconi F; Alessio L; Sagnelli C; Cavallone D; Brunetto M; Sagnelli E
    J Infect; 2013 Oct; 67(4):322-8. PubMed ID: 23796869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology and genotyping of hepatitis B virus of HBsAg-positive patients in Oman.
    Al Baqlani SA; Sy BT; Ratsch BA; Al Naamani K; Al Awaidy S; Busaidy SA; Pauli G; Bock CT
    PLoS One; 2014; 9(5):e97759. PubMed ID: 24835494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
    Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
    Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus.
    Wakil SM; Kazim SN; Khan LA; Raisuddin S; Parvez MK; Guptan RC; Thakur V; Hasnain SE; Sarin SK
    J Med Virol; 2002 Nov; 68(3):311-8. PubMed ID: 12226816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and chronicity of acute hepatitis B induced by lamivudine-resistant strains.
    Luo Q; Zhong Y; Yang Y; Xiong Q; Hu Z; Lu W; Huang P; Zhang N
    J Med Virol; 2012 Oct; 84(10):1558-61. PubMed ID: 22930503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.
    Ohkawa K; Takehara T; Kato M; Deguchi M; Kagita M; Hikita H; Sasakawa A; Kohga K; Uemura A; Sakamori R; Yamaguchi S; Miyagi T; Ishida H; Tatsumi T; Hayashi N
    J Infect Dis; 2008 Oct; 198(8):1150-8. PubMed ID: 18713056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of lamivudine-resistant mutational patterns with the antiviral effect of adefovir in patients with chronic hepatitis B.
    Cha CK; Kwon HC; Cheong JY; Cho SW; Hong SP; Kim SO; Yoo WD
    J Med Virol; 2009 Mar; 81(3):417-24. PubMed ID: 19152409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence analysis of the polymerase gene in hepatitis B virus infected blood donors in Iran.
    Sharifi Z; Yari F; Gharebaghiyan A
    Arch Iran Med; 2012 Feb; 15(2):88-90. PubMed ID: 22292578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B.
    Iacomi F; Vincenti D; Vairo F; Solmone M; Mariano A; Piselli P; Puro V; Capobianchi MR; Antonucci G
    J Med Virol; 2009 Jul; 81(7):1151-6. PubMed ID: 19475624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of complex mutational patterns in lamivudine resistant hepatitis B virus isolates.
    Neumann-Fraune M; Beggel B; Pfister H; Kaiser R; Verheyen J
    J Med Virol; 2013 May; 85(5):775-9. PubMed ID: 23408582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HBV mutations associated with lamivudine therapy.
    Lapiński TW; Parfieniuk-Kowerda A; Trzos A; Jaroszewicz J; Kowalczuk O; Nikliński J; Flisiak R
    Przegl Epidemiol; 2013; 67(4):611-6, 705-8. PubMed ID: 24741905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.
    Selabe SG; Lukhwareni A; Song E; Leeuw YG; Burnett RJ; Mphahlele MJ
    J Med Virol; 2007 Nov; 79(11):1650-4. PubMed ID: 17854040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.